Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.
Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 16, 2016 | Series C | $33M | 1 | — | — | Detail |
Jul 31, 2012 | Series A | $27M | 1 | — | — | Detail |
Nov 8, 2005 | Series Unknown | $21M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Takeda | — | Series C |
Harris and Harris Group | — | Series A |
Lansing Brown Investments | — | Series Unknown |
Cape Family Fund | — | Series Unknown |